{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T22:27:38Z","timestamp":1770416858133,"version":"3.49.0"},"reference-count":24,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2021,2,8]]},"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:p>A man with a history of blind eye due to trauma 22 years earlier consulted at 53 years of age with a large conjunctival neoplastic lesion, compromising almost the entire temporal limbus, and reaching a size of approximately 16\u2009mm on its larger diameter, in the conjunctiva. Management was started with topical and subconjunctival chemotherapy (interferon alpha-2b) in order to perform immunoreduction, but a dramatic response with total disappearance of the lesion was observed. In the follow-up time period of more than 7 years, there were no signs of recurrence.<\/jats:p>","DOI":"10.1136\/bcr-2020-240994","type":"journal-article","created":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T11:36:22Z","timestamp":1613734582000},"page":"e240994","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Topical interferon alpha-2b for a giant ocular surface squamous neoplasia: 7 years of follow-up after complete remission"],"prefix":"10.1136","volume":"14","author":[{"given":"Virgilio","family":"Galvis","sequence":"first","affiliation":[{"name":"Ophthalmology, Centro Oftalmologico Virgilio Galvis, Floridablanca, Santander, Colombia"},{"name":"Ophthalmology, Universidad Autonoma de Bucaramanga, Bucaramanga, Santander, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalia J","family":"Moreno","sequence":"additional","affiliation":[{"name":"Ophthalmology, Universidad Autonoma de Bucaramanga, Bucaramanga, Santander, Colombia"},{"name":"Ophthalmology, Centro Oftalmologico Virgilio Galvis, Floridablanca, Santander, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5081-0720","authenticated-orcid":false,"given":"Alejandro","family":"Tello","sequence":"additional","affiliation":[{"name":"Ophthalmology, Universidad Autonoma de Bucaramanga, Bucaramanga, Santander, Colombia"},{"name":"Ophthalmology, Centro Oftalmologico Virgilio Galvis, Floridablanca, Santander, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00e9stor I","family":"Carre\u00f1o","sequence":"additional","affiliation":[{"name":"Ophthalmology, Universidad Autonoma de Bucaramanga, Bucaramanga, Santander, Colombia"},{"name":"Ophthalmology, Centro Oftalmologico Virgilio Galvis, Floridablanca, Santander, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,2,19]]},"reference":[{"key":"2025082708294262000_14.2.e240994.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(05)80054-2"},{"key":"2025082708294262000_14.2.e240994.2","first-page":"109","article-title":"Conjunctival tumors: review of clinical features, risks, biomarkers, and outcomes - The 2017 J","volume":"6","author":"Shields","year":"2017","journal-title":"Donald M. Gass Lecture. Asia-Pacific J Ophthalmol"},{"key":"2025082708294262000_14.2.e240994.3","first-page":"1","article-title":"Ocular surface squamous neoplasia: population demographics, pathogenesis and risk factors","volume":"79","author":"Hollhumer","year":"2020","journal-title":"African Vis Eye Heal"},{"key":"2025082708294262000_14.2.e240994.4","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41433-018-0217-x","article-title":"A prospective study of the incidence, associations and outcomes of ocular surface squamous neoplasia in the United Kingdom","volume":"33","author":"Kiire","year":"2019","journal-title":"Eye"},{"key":"2025082708294262000_14.2.e240994.5","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0161-6420(86)33764-3","article-title":"Conjunctival and corneal intraepithelial and invasive neoplasia","volume":"93","author":"Erie","year":"1986","journal-title":"Ophthalmology"},{"key":"2025082708294262000_14.2.e240994.6","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0002-9394(84)90371-4","article-title":"Clinical and pathologic description of 17 cases of corneal intraepithelial neoplasia","volume":"97","author":"Waring","year":"1984","journal-title":"Am J Ophthalmol"},{"key":"2025082708294262000_14.2.e240994.7","first-page":"146","article-title":"Neoplasia de la superficie ocular con compromiso aislado de la c\u00f3rnea: reporte de caso y revisi\u00f3n de la literatura","volume":"51","author":"Berrospi","year":"2018","journal-title":"Rev Soc Colomb Oftalmol"},{"key":"2025082708294262000_14.2.e240994.8","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4103\/0301-4738.195010","article-title":"Recombinant interferon alpha 2b for ocular surface squamous neoplasia: an efficient and cost-effective treatment modality in Asian Indian patients","volume":"64","author":"Kaliki","year":"2016","journal-title":"Indian J Ophthalmol"},{"key":"2025082708294262000_14.2.e240994.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)90009-X"},{"key":"2025082708294262000_14.2.e240994.10","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.ophtha.2011.11.035","article-title":"Giant ocular surface squamous neoplasia managed with interferon alpha-2b as immunotherapy or immunoreduction","volume":"119","author":"Kim","year":"2012","journal-title":"Ophthalmology"},{"key":"2025082708294262000_14.2.e240994.11","doi-asserted-by":"crossref","unstructured":"Ghanavati SZ , Alizadeh R , Deng SX . Original article topical interferon alpha \u2013 2B for treatment of noninvasive ocular surface squamous neoplasia with 360 \u00b0 limbal involvement 2014;9:2008\u201311.","DOI":"10.4103\/2008-322X.150811"},{"key":"2025082708294262000_14.2.e240994.12","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4103\/0301-4738.185620","article-title":"Interferon alpha-2b in giant ocular surface squamous neoplasia","volume":"64","author":"Hernandez-Bogantes","year":"2016","journal-title":"Indian J Ophthalmol"},{"key":"2025082708294262000_14.2.e240994.13","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2008.153197"},{"key":"2025082708294262000_14.2.e240994.14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40662-019-0150-5","article-title":"Update on pharmacotherapy for ocular surface squamous neoplasia","volume":"6","author":"Al Bayyat","year":"2019","journal-title":"Eye and Vis"},{"key":"2025082708294262000_14.2.e240994.15","doi-asserted-by":"crossref","unstructured":"Theotoka D , Morkin MI , Galor A . Update on diagnosis and management of conjuntival papilloma. Eye Vis 2019;18.","DOI":"10.1186\/s40662-019-0142-5"},{"key":"2025082708294262000_14.2.e240994.16","unstructured":"Eagle RC . Eye pathology: an atlas and text. Third. Philadelphia, PA, USA: Wolters Kluwer, 2017."},{"key":"2025082708294262000_14.2.e240994.17","unstructured":"Warner MA , Stagner AM , Jakobiec FA . Epithelial tumors of the conjunctiva. In: Mannis MJ , Holland EJ , eds. Cornea. 414. Philadelphia, PA, USA: Elsevier, 2016."},{"key":"2025082708294262000_14.2.e240994.18","doi-asserted-by":"crossref","unstructured":"Harissi-Dagher M , Colby K . Tumors of the cornea and conjunctiva. In: Albert DM , Miller JW , eds. Albert & Jakobiec's Principles and Practice of Ophthalmology. Philadelphia, PA, USA: Saunders Elsevier, 2008: 792.","DOI":"10.1016\/B978-1-4160-0016-7.50061-8"},{"key":"2025082708294262000_14.2.e240994.19","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S0002-9394(14)73218-0","article-title":"Conjunctival keratoacanthoma","volume":"116","author":"Munro","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"2025082708294262000_14.2.e240994.20","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2013-303999"},{"key":"2025082708294262000_14.2.e240994.21","first-page":"e81","article-title":"Malignant transformation of a conjunctival keratoacanthoma requiring enucleation","volume":"170","author":"Diaz","year":"2019","journal-title":"Clin Ter"},{"key":"2025082708294262000_14.2.e240994.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2003.10.008"},{"key":"2025082708294262000_14.2.e240994.23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2015.09.007","article-title":"Amelanotic melanoma arising within conjunctival melanocytic intraepithelial neoplasia sine pigmento","volume":"122","author":"Betts","year":"2015","journal-title":"Ophthalmology"},{"key":"2025082708294262000_14.2.e240994.24","doi-asserted-by":"crossref","DOI":"10.1001\/jamaophthalmol.2015.3568","article-title":"Amelanotic conjunctival melanoma","volume":"134","author":"Damani","year":"2016","journal-title":"JAMA Ophthalmol"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-240994","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T15:29:52Z","timestamp":1756308592000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-240994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":24,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2,19]]},"published-print":{"date-parts":[[2021,2]]}},"alternative-id":["10.1136\/bcr-2020-240994"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-240994","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2]]}}}